Abstract

The current trend in clinical data analysis is to understand how individuals respond to therapies and drug interactions based on their genetic makeup. This has led to a paradigm shift in healthcare; caring for patients is now 99% information and 1% intervention. Reducing costs of next generation sequencing (NGS) technologies has made it possible to take genetic profiling to the clinical setting. This requires not just fast and accurate algorithms for variant detection, but also a knowledge-base for variant annotation and prioritization to facilitate tailored therapeutics based on an individual's genetic profile. Here we show that it is possible to provide a fast and easy access to all possible information about a variant and its impact on the gene, its protein product, associated pathways and drug-variant interactions by integrating previously reported knowledge from various databases. With this objective, we have developed a pipeline, Sequence Variants Identification and Annotation (SeqVItA) that provides end-to-end solution for small sequence variants detection, annotation and prioritization on a single platform. Parallelization of the variant detection step and with numerous resources incorporated to infer functional impact, clinical relevance and drug-variant associations, SeqVItA will benefit the clinical and research communities alike. Its open-source platform and modular framework allows for easy customization of the workflow depending on the data type (single, paired, or pooled samples), variant type (germline and somatic), and variant annotation and prioritization. Performance comparison of SeqVItA on simulated data and detection, interpretation and analysis of somatic variants on real data (24 liver cancer patients) is carried out. We demonstrate the efficacy of annotation module in facilitating personalized medicine based on patient's mutational landscape. SeqVItA is freely available at https://bioinf.iiit.ac.in/seqvita.

Highlights

  • Precision medicine is an emerging approach for risk assessment to diagnosis, disease prognosis, and treatment that considers individual genetic variability into account

  • We discuss ability of the “annotate” module in Sequence Variants Identification and Annotation (SeqVItA) in analyzing the mutational landscape across 24 liver cancer patients, and prioritize the somatic variants to understand the probable role of novel variants in tumorigenesis

  • Analysis of multiple genes quickly, and sensitively from small sample quantities is desirable, which is possible with the advent of Generation Sequencing (NGS) techniques

Read more

Summary

Introduction

Precision medicine is an emerging approach for risk assessment to diagnosis, disease prognosis, and treatment that considers individual genetic variability into account. It requires analyzing multiple genes quickly and sensitively from small quantities of sample, which is possible with the advent of generation sequencing (NGS) techniques. Targeted sequencing (TS) is widely used in the form of gene panels, e.g., hotspot panels (either clinically actionable or with diagnostic/prognostic significance), actionable gene panels (includes all exons of targeted genes), and disease-focused gene panels. The revolution of high-throughput sequencing technologies has made it possible to carry out genome-wide analysis of somatic mutations in population-scale cancer cohorts

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call